Atul Chopra
Hoofd Techniek/Wetenschap/O&O bij Aceragen, Inc. (North Carolina)
Vermogen: 968 947 $ op 31-07-2023
Actieve functies van Atul Chopra
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Aceragen, Inc. (North Carolina)
 Aceragen, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Aceragen, Inc., Aceragen, Inc. is a biopharmaceutical company that develops therapeutics for orphan diseases. The company is based in Durham, NC. The company was founded in 2021 by John Clayton Taylor. Aceragen, Inc. (North Carolina) was acquired by Idera Pharmaceuticals, Inc. on September 28, 2022. | Hoofd Techniek/Wetenschap/O&O | 01-03-2021 | - |
| Directeur/Bestuurslid | 01-03-2021 | - |
Loopbaan van Atul Chopra
Statistieken
Internationaal
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Aceragen, Inc. (North Carolina)
Aceragen, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Aceragen, Inc., Aceragen, Inc. is a biopharmaceutical company that develops therapeutics for orphan diseases. The company is based in Durham, NC. The company was founded in 2021 by John Clayton Taylor. Aceragen, Inc. (North Carolina) was acquired by Idera Pharmaceuticals, Inc. on September 28, 2022. | Health Technology |
- Beurs
- Insiders
- Atul Chopra
- Ervaring
